A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
RPTH Journal shared on LinkedIn about a recent article by Ying Dai et al, adding:
”Measuring plasmin generation: a smarter tool for studying fibrinolysis
Fibrinolysis is tightly regulated by plasmin.
Yet reliably measuring plasmin generation in preclinical and clinical settings has remained challenging.
A new study in RPTH Journal presents a novel fluorescence-based plasmin sensor (FPS) designed to address this gap.
Key findings:
- FPS showed higher efficiency for plasmin than existing peptide-based sensors
- Unlike peptide sensors, FPS is not cleaved by plasmin inhibited by α2-macroglobulin giving a more accurate readout
- FPS interacts with kringle domain 5 of plasmin, revealing novel molecular interactions
- When combined with an anti-α2-antiplasmin blocking antibody, FPS can detect nanomolar levels of plasmin
- FPS does not inhibit clot lysis, a key advantage over peptide sensors
- Plasmin generation measured with FPS showed only 2-fold variation across healthy volunteers — suggesting good reproducibility
- The sensor can also detect the influence of PAI-1 when antiplasmin is inhibited
Better tools to measure plasmin generation could significantly advance our understanding of fibrinolytic disorders and ultimately improve how we diagnose and manage conditions like hyperfibrinolysis or thrombosis.”
Title: A novel biosensor for measuring plasmin activity
Authors: Ying Dai, Paul Y. Kim, Stefan Heitmeier, Jeffrey I. Weitz, Peter L. Gross
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 17:27John Strouse: Building Standards for Whole-Person Sickle Cell Care Through Collaboration
-
Oct 17, 2026, 17:20Jean-Jacques Kiladjian: Exploring the Future of Polycythemia Vera Treatment at MPN Horizons 2026
-
Oct 17, 2026, 17:10Habib Bennaceur: Strengthening Collaboration in Haemophilia, Sickle Cell Disease and Thalassaemia in India
-
Oct 17, 2026, 16:58Danny Hsu: Building Connections at the AUSNBled Collaborative Dinner in Auckland
-
Oct 17, 2026, 16:48Kalyan Roy: Enhancing Patient Experience Through Learning and Collaboration
-
Oct 17, 2026, 16:43Wilfried Dinh: Antiplatelet Therapy in 2026: Duration is Becoming a Dynamic Decision
-
Oct 17, 2026, 16:37Ian Setchfield: Dr. Evans Presents on Safe Anticoagulation Prescribing at East Kent Hospitals
-
Oct 17, 2026, 16:33Lewis Thomas: Connecting Through Shared Experiences at ASCAT 2026
-
Oct 17, 2026, 16:29Nilesh Jethwa: Yasmin Adverse Event Reports Exceed 23,000 Over Two-Year Period